Welcome to our dedicated page for Joint news (Ticker: JYNT), a resource for investors and traders seeking the latest updates and insights on Joint stock.
The Joint Corp (NASDAQ: JYNT) operates one of the nation's largest chiropractic networks through its innovative corporate-owned and franchise clinic model. This page serves as the definitive source for investors and industry observers tracking the company's latest developments.
Access official press releases, financial updates, and operational announcements in one centralized location. Our curated collection focuses on material events including quarterly earnings reports, franchise expansion initiatives, leadership updates, and strategic partnerships that shape the company's position in the healthcare sector.
All content undergoes strict verification to ensure accuracy and relevance for stakeholders. The streamlined format enables quick scanning of key developments while maintaining depth for detailed analysis. Regular updates reflect JYNT's evolving role in making chiropractic care more accessible through its unique membership-based model.
Bookmark this page for efficient monitoring of Joint Corp's progress in transforming retail healthcare delivery. Combine these verified updates with SEC filings and market analysis for comprehensive investment research.
The Joint Corp (NASDAQ: JYNT) reported Q3 2025 results: revenue $13.4M (+6% YoY), consolidated net income $855,000, and net income from continuing operations $290,000. Consolidated Adjusted EBITDA rose 36% to $3.3M; Adjusted EBITDA from continuing operations improved to $1.4M. System-wide sales were $127.3M (-1.5%) and comp sales were (2.0)%. Unrestricted cash was $29.7M and an undrawn $20M credit line remains available.
The board authorized an additional $12M for share repurchases after repurchasing 540,000 shares for ~$5M year-to-date. Company reached initial agreement to sell 45 clinics for $4.5M; terms are being negotiated. 2025 guidance updated: system-wide sales $530M–$534M; comp sales (1)%–0%; consolidated Adjusted EBITDA $10.8M–$11.8M.
The Joint Corp (NASDAQ: JYNT) announced on Nov 5, 2025 that its board authorized an additional $12 million for its stock repurchase program.
Management said this follows completion of the first $5 million tranche, which repurchased 540,000 shares between August and October. Repurchases may occur in open-market or privately negotiated transactions and will be made at the discretion of the company’s finance committee, subject to securities laws and market conditions. The program does not obligate the company to buy any specific amount of common stock.
The Joint Corp (NASDAQ: JYNT) will report third quarter 2025 financial results on Thursday, November 6, 2025 after the market close. A conference call with President and CEO Sanjiv Razdan and CFO Scott Bowman will be held at 5:00 p.m. EST to discuss the results.
Investors can join live by dialing (833) 630-0823 or (412) 317-1831 (ask to be joined into the ‘The Joint’ call about 15 minutes before start). A live webcast and accompanying slide presentation will be available in the investor relations events section at https://ir.thejoint.com/events. The webcast replay will be archived for about one year; an audio replay is available through Thursday, November 13, 2025 at (877) 344-7529 or (412) 317-0088 with conference ID 3346890.
The Joint Corp (NASDAQ: JYNT) was named to the Franchise Times Top 400 for 2025, ranking 139 and moving up 11 spots year-over-year. This marks the company's sixth year inside the top 200 franchised systems by global, systemwide sales. The company highlighted growth across the health and medical and personal services sectors and emphasized its retail clinic model offering no-appointment, no-insurance-hassle, affordable chiropractic care with extended hours. Leadership said the ranking validates the brand and supports continued expansion to increase access to routine chiropractic services nationwide.
The Joint Corp (NASDAQ: JYNT) opened its first clinic in Delaware on Oct 3, 2025, expanding its retail chiropractic footprint to 43 states plus D.C.
The Dover clinic at 50 North Dupont Highway is owned by franchisees Troy and Dr. Cherese Bratcher; it is their second Joint location (also in Knightdale, NC). The release emphasizes The Joint's no-appointment, no-insurance model, affordable pricing, extended hours, and focus on routine chiropractic care and community access.
The Joint Corp. (NASDAQ: JYNT), the nation's largest chiropractic care provider, has appointed Debbie L. Gonzalez as its new Chief Marketing Officer effective October 7, 2025. Gonzalez, who brings extensive experience in brand strategy and multi-site retail marketing, will replace Lori Abou Habib.
The new CMO has a strong background in franchise operations and wellness industry, notably having led the wellness franchise membership model at Massage Envy. Her expertise spans brand development, performance marketing, customer acquisition, and digital innovation for public, private, and consulting companies.
The Joint Corp (NASDAQ: JYNT) reported Q2 2025 financial results, highlighting a strategic shift toward becoming a pure-play franchisor. Revenue grew 5% to $13.3 million, with system-wide sales increasing 2.6% to $129.6 million. The company refranchised 37 clinics for $11.2 million and acquired Northwest regional developer territory rights for $2.8 million.
The company reported consolidated net income of $93,000, improving from a $3.6 million loss in Q2 2024. Adjusted EBITDA from consolidated operations increased 52% to $3.2 million. Due to softer sales trends, JYNT revised its 2025 guidance, now expecting system-wide sales of $530-550 million and low single-digit comp sales growth.
The total clinic count reached 967, with franchised clinics now representing 92% of the portfolio. The company maintains $29.8 million in unrestricted cash and a $20 million credit line.
The Joint Corp. (NASDAQ: JYNT) announced plans to restate its financial statements for full-year 2024 and Q1 2025 due to errors in calculating impairment charges for clinics held for sale. The restatement is expected to reduce the 2024 net loss by $2.2 million and increase Q1 2025 net income by $0.5 million, resulting in a cumulative $2.7 million increase in the carrying value of assets held for sale.
The company identified a misapplication of accounting guidance related to the valuation methodology for assets held for sale. While the restatement will not impact Adjusted EBITDA, cash positions, or restricted cash for either period, the company expects to report a material weakness in internal control over financial reporting and ineffective disclosure controls.
The Joint Corp. (NASDAQ: JYNT), the largest franchisor of chiropractic care through The Joint Chiropractic network, has scheduled its second quarter 2025 financial results announcement for Thursday, August 7, 2025, after market close.
The company will host a conference call at 5:00 p.m. EDT featuring President and CEO Sanjiv Razdan and CFO Scott Bowman. Investors can access the call by dialing (833) 630-0823 or (412) 317-1831. A live webcast with slides will be available on the company's IR events page, and an audio archive will be accessible for one week.
The Joint Corp (NASDAQ: JYNT) has completed a significant transaction involving the sale of 31 corporate-owned clinics in Arizona and New Mexico to Joint Ventures, LLC for $8.3 million in cash. As part of the deal, JYNT acquired regional developer rights in the Northwest region, which generated $855,000 in royalties and franchise fees over the 12 months ended March 31, 2025.
The acquired Northwest territory rights cover 46 existing franchised clinics and 30 sites for future development. Joint Ventures, one of JYNT's strongest franchisees, will grow to 96 clinics and has committed to opening 10 additional locations. The company expects this refranchising initiative to strengthen its business model, reduce commission obligations, and increase operating margins.
FAQ
What is the current stock price of Joint (JYNT)?
What is the market cap of Joint (JYNT)?
